Publicaciones en colaboración con investigadores/as de Karolinska Institute (299)

2024

  1. A genome-wide association meta-analysis of all-cause and vascular dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995

  2. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Scientific reports, Vol. 14, Núm. 1, pp. 3000

  3. Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 6146-6160

  4. Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia

    Neurology, Vol. 103, Núm. 7

  5. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6722-6739

  6. Blood-based multivariate methylation risk score for cognitive impairment and dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6682-6698

  7. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 6205-6220

  8. Correction to: Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort (European Journal of Nutrition, (2016), 55, 1, (7-20), 10.1007/s00394-014-0818-5)

    European Journal of Nutrition

  9. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  10. Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. e917-e928

  11. Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study

    eClinicalMedicine, Vol. 75

  12. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  13. Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants with Genetic Frontotemporal Dementia

    Neurology, Vol. 103, Núm. 8

  14. Frontoparietal network integrity supports cognitive function in pre-symptomatic frontotemporal dementia: Multimodal analysis of brain function, structure, and perfusion

    Alzheimer's and Dementia

  15. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  16. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project

    Gut Microbes, Vol. 16, Núm. 1

  17. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes

    Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359

  18. Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterol

    Frontiers in Cellular Neuroscience, Vol. 18

  19. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  20. Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study

    Brain, Behavior, and Immunity, Vol. 122, pp. 231-240